Allarity Therapeutics, Inc. Restricted Cash, Current
Allarity Therapeutics, Inc. (ALLR) had Restricted Cash, Current of $10.00 million as of 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Balance Sheet › Assets › Assets, Current › Cash, Cash Equivalents, and Short-Term Investments
us-gaap:RestrictedCashCurrent · last filed 2026-08-14
- 2026-06-30: Restricted Cash, Current $10.00M.
- 2026-03-31: Restricted Cash, Current $10.00M.
- 2025-12-31: Restricted Cash, Current $0.00.
- 2025-06-30: Restricted Cash, Current $0.00.
| Period end | Restricted Cash, Current |
|---|---|
| 2026-06-30 | $10.00M 10-Q · filed 2026-08-14 |
| 2026-03-31 | $10.00M 10-Q · filed 2026-05-15 |
| 2025-12-31 | $0.00 10-Q · filed 2026-08-14 |
| 2025-06-30 | $0.00 10-Q · filed 2026-08-14 |
| 2025-03-31 | $2.50M 10-Q · filed 2026-05-15 |
| 2024-12-31 | $0.00 10-Q · filed 2025-05-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |
| Lipocine Inc. (LPCN) | United States | $0.017B | -1.79 |
| Pasithea Therapeutics Corp. (KTTA) | United States | $0.017B | -0.81 |
| Biofrontera Inc. (BFRI) | United States | $0.018B | -2.13 |
| Korsana Biosciences, Inc. (CYCN) | United States | $0.016B | |
| Citius Pharmaceuticals, Inc. (CTXR) | United States | $0.016B | -133.06 |
| Rocket One Inc. (RKTO) | United States | $0.019B | |
| Lantern Pharma Inc. (LTRN) | United States | $0.015B | -2.87 |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| Anebulo Pharmaceuticals, Inc. (ANEB) | United States | $0.015B |